Core Viewpoint - The company, Qiming Medical-B (02500.HK), has filed a patent infringement lawsuit against Edwards Lifesciences Corp. and Edwards Lifesciences LLC through its wholly-owned subsidiary, Cardiovalve Ltd., in the U.S. District Court for Delaware [1] Company Summary - Qiming Medical-B has a market capitalization of HKD 1.491 billion and ranks 17th in the medical device II industry [1] - The company has a Return on Equity (ROE) of -26.56%, significantly lower than the industry average of -4.82% [1] - The company's operating revenue stands at HKD 427 million, compared to the industry average of HKD 1.201 billion, placing it 18th in the industry [1] - The net profit margin is -72.02%, while the industry average is -19.02%, ranking 26th [1] - The gross profit margin is 73.74%, which is higher than the industry average of 53.75%, ranking 2nd [1] - The company's debt ratio is 33.77%, compared to the industry average of 29.81%, ranking 21st [1] Industry Summary - There has been low attention from investment banks towards Qiming Medical-B, with no ratings given in the past 90 days [1]
启明医疗-B(02500.HK)确认其并不知悉有任何资料须予公布以避免公司证券出现虚假市场 或有任何内幕消息须予以披露